Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Lilly Launches Mounjaro Multi-Dose Pen in China for Diabetes and Weight Management
June 13, 2025
Company
Deals
XtalPi Acquires Liverpool ChiroChem to Boost AI-Driven Drug Discovery
June 12, 2025
Company
Deals
Shandong Boan Partners with Shanghai Pharma for BA5101 Diabetes Drug
June 12, 2025
Company
Deals
GCCF and CTTQ Explore Collaboration to Expand Innovative Drug Access in Hong Kong
June 12, 2025
Company
Drug
ImmVira Commences Phase II Trial for MVR-T3011 in High-Risk NMIBC
June 26, 2025
Company
Deals
Escugen Partners with SovranBio to Accelerate Development of Antibody-Drug Conjugates
June 12, 2025
Company
Medical Device
Varian Medical Systems Secures NMPA Approval for Ethos 2.0 AI Radiotherapy Platform
June 12, 2025
Company
Novo Nordisk China Restructures to Form New Obesity and Diabetes Department
June 12, 2025
Company
Deals
Eli Lilly Partners with Juvena Therapeutics on Muscle Health AI Platform
June 12, 2025
Company
Drug
Daiichi Sankyo Launches Phase I Trial for Enhertu Subcutaneous Formulation
June 12, 2025
Medical Device
Policy / Regulatory
NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification
June 12, 2025
Policy / Regulatory
China Updates Class 3 Hospital Accreditation Standards for 2025
June 12, 2025
1
2
…
16
17
18
19
20
…
27
28
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
